# ESPEROCT

NDC: 0169-8100
Generic name: antihemophilic factor (recombinant), glycopegylated-exei
Labeler / Manufacturer: Novo Nordisk
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20190219

FDA application: BLA125671

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-8100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-8100